Skip to main content
Top
Published in: Clinical Rheumatology 6/2020

01-06-2020 | Vulgar Psoriasis | Original Article

Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America

Authors: Enrique Roberto Soriano, Federico Zazzetti, Ivanio Alves Pereira, José Maldonado Cocco, Valderilio Feijó Azevedo, Generoso Guerra, Wilson Bautista-Molano, Julio César Casasola, David Vega Morales, Diana Rocío Gil, Steve Lobosco, Fabio Lawson

Published in: Clinical Rheumatology | Issue 6/2020

Login to get access

Abstract

Introduction

Physician-patient misalignment may exist in real-life clinical practice. We aimed to assess physician and patient treatment satisfaction levels and associated degree of misalignment in psoriatic arthritis (PsA).

Method

Data from a cross-sectional survey of patients and their physicians conducted in Latin America were analyzed. Physician-reported and patient-reported satisfaction levels with current PsA treatment, alignment in satisfaction levels, and factors associated with satisfaction misalignment were assessed through bivariable and multivariable regression analyses.

Results

A total of 179 physician-patient pairs were analyzed. Physicians reported satisfaction with current disease control in 87.7% (n = 157) of cases; patients reported satisfaction in 91.1% (n = 163 of cases). A total of 82.1% of physician-patient pairs were aligned. Compared with aligned patients, misaligned patients were older and more likely to have moderate or severe disease, deteriorating or unstable disease, a past hospital procedure, current or past psoriasis symptoms, greater current pain, a current acute episode, poorer health and quality of life, greater impairment, poorer medication compliance, to consider PsA a major daily burden, and to believe that PsA treatments were ineffective. Misaligned patients were less likely to be in remission. Logistic regression analysis revealed that misaligned patients were older, and more likely to consider PsA a major daily burden and PsA treatments as ineffective.

Conclusions

High levels of treatment satisfaction and alignment were observed among PsA patients and their physicians in Latin America. Patients in this study nevertheless experienced a considerable clinical and quality-of-life burden, especially the misaligned patients. Addressing misalignment may lead to improved PsA disease control.
Key points
• High treatment satisfaction was observed among PsA patients and their treating physicians in Latin America.
• Patients experienced a considerable clinical and quality-of-life burden, especially the misaligned patients.
• One-fifth of physician-patient pairs were misaligned regarding satisfaction.
• Understanding and addressing misalignment may improve outcomes in this patient population.
Appendix
Available only for authorised users
Literature
3.
5.
go back to reference Ranza R, Carneiro S, Qureshi AA, Martins G, Rodrigues JJ, Romiti R, Barros TB, Carneiro J, Sampaio AL, Grynszpan R, Markus J, Pinto RM, Goldenstein-Schainberg C (2015) Prevalence of psoriatic arthritis in a large cohort of Brazilian patients with psoriasis. J Rheumatol 42(5):829–834. https://doi.org/10.3899/jrheum.140474 CrossRefPubMed Ranza R, Carneiro S, Qureshi AA, Martins G, Rodrigues JJ, Romiti R, Barros TB, Carneiro J, Sampaio AL, Grynszpan R, Markus J, Pinto RM, Goldenstein-Schainberg C (2015) Prevalence of psoriatic arthritis in a large cohort of Brazilian patients with psoriasis. J Rheumatol 42(5):829–834. https://​doi.​org/​10.​3899/​jrheum.​140474 CrossRefPubMed
8.
go back to reference Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, Emery P, Landewe R, Oliver S, Aletaha D, Betteridge N, Braun J, Burmester G, Canete JD, Damjanov N, FitzGerald O, Haglund E, Helliwell P, Kvien TK, Lories R, Luger T, Maccarone M, Marzo-Ortega H, McGonagle D, McInnes IB, Olivieri I, Pavelka K, Schett G, Sieper J, van den Bosch F, Veale DJ, Wollenhaupt J, Zink A, van der Heijde D (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75(3):499–510. https://doi.org/10.1136/annrheumdis-2015-208337 CrossRefPubMed Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, Emery P, Landewe R, Oliver S, Aletaha D, Betteridge N, Braun J, Burmester G, Canete JD, Damjanov N, FitzGerald O, Haglund E, Helliwell P, Kvien TK, Lories R, Luger T, Maccarone M, Marzo-Ortega H, McGonagle D, McInnes IB, Olivieri I, Pavelka K, Schett G, Sieper J, van den Bosch F, Veale DJ, Wollenhaupt J, Zink A, van der Heijde D (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75(3):499–510. https://​doi.​org/​10.​1136/​annrheumdis-2015-208337 CrossRefPubMed
9.
go back to reference Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O’Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, Tuong W, Ritchlin CT (2016) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis Rheum 68(5):1060–1071. https://doi.org/10.1002/art.39573 CrossRef Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O’Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, Tuong W, Ritchlin CT (2016) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis Rheum 68(5):1060–1071. https://​doi.​org/​10.​1002/​art.​39573 CrossRef
10.
go back to reference Elmamoun M, Eraso M, Maharaj A, Chandran V, Coates L, Adebajo A, Sharma A, Toloza S, Vega-E L, Vega-H O, Abogamal A, Ajibade A, Ayanlowo O, Azevedo V, Bautista-M W, Carneiro S, Goldenstein-S C, Hernandez-V F, Ima-E U, Lima A, Medina-R J, Mody G, Narang T, Ortega-L A, Ranza R (2018) OP0312 International League Of Associations for Rheumatology (ILAR) treatment recommendations for psoriatic arthritis in resource-poor countries. Ann Rheum Dis 77(Suppl 2):203–203. https://doi.org/10.1136/annrheumdis-2018-eular.5536 CrossRef Elmamoun M, Eraso M, Maharaj A, Chandran V, Coates L, Adebajo A, Sharma A, Toloza S, Vega-E L, Vega-H O, Abogamal A, Ajibade A, Ayanlowo O, Azevedo V, Bautista-M W, Carneiro S, Goldenstein-S C, Hernandez-V F, Ima-E U, Lima A, Medina-R J, Mody G, Narang T, Ortega-L A, Ranza R (2018) OP0312 International League Of Associations for Rheumatology (ILAR) treatment recommendations for psoriatic arthritis in resource-poor countries. Ann Rheum Dis 77(Suppl 2):203–203. https://​doi.​org/​10.​1136/​annrheumdis-2018-eular.​5536 CrossRef
11.
go back to reference Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J (2019) Special article: 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheum 71(1):5–32. https://doi.org/10.1002/art.40726 CrossRef Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J (2019) Special article: 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheum 71(1):5–32. https://​doi.​org/​10.​1002/​art.​40726 CrossRef
17.
go back to reference Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M (1997) Issues in the measurement of satisfaction with treatment. Am J Manag Care 3(4):579–594PubMed Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M (1997) Issues in the measurement of satisfaction with treatment. Am J Manag Care 3(4):579–594PubMed
24.
go back to reference Korman NJ, Zhao Y, Pike J, Roberts J, Sullivan E, Kemhus M (2016) Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions. Dermatol Online J 22(7) Korman NJ, Zhao Y, Pike J, Roberts J, Sullivan E, Kemhus M (2016) Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions. Dermatol Online J 22(7)
29.
go back to reference van Reenen MOM (2015) EQ-5D-3L User Guide. EuroQol Research Foundation, Rotterdam van Reenen MOM (2015) EQ-5D-3L User Guide. EuroQol Research Foundation, Rotterdam
30.
go back to reference Khanna D, Krishnan E, Dewitt EM, Khanna PP, Spiegel B, Hays RD (2011) The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS). Arthritis Care Res 63(Suppl 11):S486–S490. https://doi.org/10.1002/acr.20581 CrossRef Khanna D, Krishnan E, Dewitt EM, Khanna PP, Spiegel B, Hays RD (2011) The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS). Arthritis Care Res 63(Suppl 11):S486–S490. https://​doi.​org/​10.​1002/​acr.​20581 CrossRef
32.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef
36.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRef
38.
go back to reference Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD (2015) Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care Res 67(2):264–272. https://doi.org/10.1002/acr.22401 CrossRef Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD (2015) Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care Res 67(2):264–272. https://​doi.​org/​10.​1002/​acr.​22401 CrossRef
39.
go back to reference Kostova Z, Caiata-Zufferey M, Schulz PJ (2014) The process of acceptance among rheumatoid arthritis patients in Switzerland: a qualitative study. Pain Res Manag 19(2):61–68CrossRef Kostova Z, Caiata-Zufferey M, Schulz PJ (2014) The process of acceptance among rheumatoid arthritis patients in Switzerland: a qualitative study. Pain Res Manag 19(2):61–68CrossRef
42.
go back to reference Cherubini P, Rumiati R, Bigoni M, Tursi V, Livi U (2003) Long-term decrease in subjective perceived efficacy of immunosuppressive treatment after heart transplantation. J Heart Lung Transplant 22(12):1376–1380CrossRef Cherubini P, Rumiati R, Bigoni M, Tursi V, Livi U (2003) Long-term decrease in subjective perceived efficacy of immunosuppressive treatment after heart transplantation. J Heart Lung Transplant 22(12):1376–1380CrossRef
43.
go back to reference Garcia Popa-Lisseanu MG, Greisinger A, Richardson M, O’Malley KJ, Janssen NM, Marcus DM, Tagore J, Suarez-Almazor ME (2005) Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 32(5):913–919PubMed Garcia Popa-Lisseanu MG, Greisinger A, Richardson M, O’Malley KJ, Janssen NM, Marcus DM, Tagore J, Suarez-Almazor ME (2005) Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 32(5):913–919PubMed
Metadata
Title
Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America
Authors
Enrique Roberto Soriano
Federico Zazzetti
Ivanio Alves Pereira
José Maldonado Cocco
Valderilio Feijó Azevedo
Generoso Guerra
Wilson Bautista-Molano
Julio César Casasola
David Vega Morales
Diana Rocío Gil
Steve Lobosco
Fabio Lawson
Publication date
01-06-2020
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 6/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04870-1

Other articles of this Issue 6/2020

Clinical Rheumatology 6/2020 Go to the issue